INDIAN BENCHMARK have a subdued opening
in wake of the negative cues from the global front. Shasun Pharma
extends rally on acquiring global rights of Ibuprofen, Nuprin.
FURTHER, Titan is
trading higher by 2% extending its previous day's 3.4% gain, after reporting
11.6% year-on-year (yoy) jump in net profit at Rs 206 crore for the fourth
quarter ended March 31, 2014. HCL Technologies and DNB Bank announces US$ 400
mn strategic engagement.
Trend in FII flows: The FIIs
were net buyers of Rs 45cr in the cash segment on Tuesday while the
domestic institutional investors (DIIs) were net sellers of Rs. 55cr,
as per the provisional figures released by the NSE.
Summer
Special Offer
Limited
Time offer
Offer
Date-02 May 2014 To 12 May 2014
Click Here:- 2 days free trial
www.capitalstars.com/services.phpClick Here:- 2 days free trial
0 Comments